Stocksigma LogoStocksigma Logo

Kotak Mahindra Mutual Fund Acquires Over 5% Stake in Molbio Diagnostics

Kotak Mahindra Mutual Fund (KMMF) crossed the 5% regulatory threshold in Molbio Diagnostics Ltd on 8th Oct'26 through an open market transaction

Kotak Mahindra Mutual Fund Acquires Over 5% Stake in Molbio Diagnostics

Molbio Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 16 Oct 2026, 3:43 pm

Kotak Mahindra Mutual Fund Acquires Over 5% Stake in Molbio Diagnostics Kotak Mahindra Mutual Fund (KMMF) crossed the 5% regulatory threshold in Molbio Diagnostics Ltd on 8th Oct'26 through an open market transaction. KMMF acquired 570,000 equity shares, representing a 0.4946% stake in the company. Following this acquisition, KMMF鈥檚 total holding increased from 5,749,083 shares (4.9888%) to 6,319,083 equity shares, raising its aggregate shareholding and voting rights to 5.4834% of Molbio Diagnostics' total paid-up equity share capital.

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements